What is Quviviq
QUVIVIQ (daridorexant) is a prescription medication designed to treat insomnia in adults who have trouble falling asleep or staying asleep. It functions as a dual orexin receptor antagonist (DORA), blocking the activity of orexin, a neuropeptide that promotes wakefulness. By inhibiting orexin's action, QUVIVIQ helps reduce overactive wake signals, facilitating the ability to fall asleep faster and maintain sleep throughout the night.
Clinical trials have demonstrated QUVIVIQ's efficacy and safety. In studies involving over 1,800 adults, participants taking QUVIVIQ every night reported significant improvements in sleep onset and maintenance, with noticeable benefits observed after one week and sustained over three months. Additionally, the 50 mg dose notably reduced patient-reported daytime sleepiness, suggesting improvements in daytime functioning.
£20 per week
